Skip to main content
Clinical Trials/IRCT2017013132319N1
IRCT2017013132319N1
Recruiting
未知

The comparison of therapeutic effect on severity and number of skin lesions, between metformin semisolid formulation and placebo, in patients with mild to moderate Acne vulgaris.

Shiraz University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Acne vulgaris.
Sponsor
Shiraz University of Medical Sciences
Enrollment
20
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with mild to moderate acne, defined as a score of 1 to 30 on the global acne grading system (GAGS) scale, who did not get any treatment before, or were not satisfied with their previous acne therapies, will be participated in the study after giving written informed consent. Exclusion criteria: Patients will be excluded if they are diabetic or have an uncontrolled systemic disease; have received topical anti acne therapy two months before or during the study or any systemic therapy, 30 days before or during the study; were known to be allergic or sensitive to any of the study medications or their components; have a skin disease that might interfere with the diagnosis or evaluation of their skin lesions; pregnant women and lactating ones.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials